PDCD1 and melanoma: In order to study the differences in immunotherapy and chemotherapy of different immune molecular subtypes, we used the method of subclass mapping to compare the three metabolic subtypes with the GSE91061 dataset (melanoma receiving anti-PD-1 and anti-CTLA-4 treatment).